Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage

Molecular Medicine Reports

Volumn 7, Issue 4, 2013, Pages 1261-1266

  Li, Xiong ^a   Wang, Rong ^a   Wang, Xuejiang ^b   Xue, Xiaowei ^b   Ran, Duan ^a   Wang, Shuo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral arteriovenous malformation; Hemorrhage; Interleukin 6; Matrix metalloproteinase 9; Plasma

Indexed keywords

EOSIN; GELATINASE A; GELATINASE B; HEMATOXYLIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TRANSCRIPTION FACTOR;

ADULT; ARTERIOVENOUS MALFORMATION; ARTICLE; BLOOD; BLOOD LEVEL; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LOBECTOMY; MALE; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; RISK ASSESSMENT; STAINING; TEMPORAL LOBE; WESTERN BLOTTING; ZYMOGRAPHY;

ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; GENE EXPRESSION REGULATION; HEMORRHAGE; HUMANS; INTERLEUKIN-6; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; RNA, MESSENGER;

EID: 84875266721     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1332     Document Type: Article

References (30)

1. ApSimon HT, Reef H, Phadke RV and Popovic EA: A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke 33: 2794-2800, 2002.
2. Crawford PM, West CR, Chadwick DW and Shaw MD: Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 49: 1-10, 1986.
3. Fults D and Kelly DL Jr: Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery 15: 658-662, 1984.
4. Martin NA and Vinters HV: Arteriovenous malformations. In: Neurovascular Surgery. Carter LP, Spetzler RF and Hamilton MG (eds). McGraw-Hill, New York, pp875-903, 1994.
5. Chen Y, Pawlikowska L, Yao JS, et al: Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59: 72-80, 2006.
6. Okazaki S, Furukado S, Abe Y, et al: Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients. Cerebrovasc Dis 30: 180-187, 2010.
7. Chen Y, Zhu W, Bollen AW, et al: Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery 62: 1340-1350, 2008.
8. Fishman D, Faulds G, Jeffery R, et al: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376, 1998.
9. Feiler S, Plesnila N, Thal SC, et al: Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis 32: 289-295, 2011.
10. Loftus IM, Naylor AR, Goodall S, et al: Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31: 40-47, 2000.
11. Chyatte D and Lewis I: Gelatinase activity and the occurrence of cerebral aneurysms. Stroke 28: 799-804, 1997.
12. Sandalcioglu IE, Asgari S, Wende D, et al: Proliferation activity is significantly elevated in partially embolized cerebral arteriovenous malformations. Cerebrovasc Dis 30: 396-401, 2010.
13. Choi EJ, Walker EJ, Shen F, et al: Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis 33: 540-547, 2012.
14. Terry CF, Loukaci V and Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275: 18138-18144, 2000.
15. Rundek T, Elkind MS, Pittman J, et al: Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33: 1420-1423, 2002.
16. Jones KG, Brull DJ, Brown LC, et al: Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103: 2260-2265, 2001.
17. Brull DJ, Leeson CP, Montgomery HE, et al: The effect of the Interleukin-6-174G>C promoter gene polymorphism on endothelial function in healthy volunteers. Eur J Clin Invest 32: 153-157, 2002.
18. Acalovschi D, Wiest T, Hartmann M, et al: Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864-1869, 2003.
19. Hernández-Rodríguez J, Segarra M, Vilardell C, et al: Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 107: 2428-2434, 2003.
20. Hashimoto T, Lawton MT, Wen G, et al: Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54: 410-425, 2004.
21. Aoki Y, Jaffe ES, Chang Y, et al: Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93: 4034-4043, 1999.
22. Gaudino M, Andreotti F, Zamparelli R, et al: The-174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 108 (Suppl 1): II195-II199, 2003.
23. Pola R, Flex A, Gaetani E, et al: Synergistic effect of -174G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 34: 881-885, 2003.
24. Flex A, Gaetani E, Pola R, et al: The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 24: 264-268, 2002.
25. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
26. Brinckerhoff CE and Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207-214, 2002.
27. Chen Y, Pawlikowska L, Yao JS, et al: Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59: 72-80, 2006.
28. Hashimoto T, Wu Y, Lawton MT, et al: Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery 56: 1058-1065, 2005.
29. Achrol AS, Pawlikowska L, McCulloch CE, et al: Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37: 231-234, 2006.
30. Kim H, Hysi PG, Pawlikowska L, et al: Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis 27: 176-182, 2009.